Form D Explorer

Form C — AlphaRose Therapeutics Inc

0001665160-25-000154 · filed 2025-01-29 · via StartEngine Primary, LLC

Offering

Target
$123,998
Maximum
$1,234,997
Security type
Common Stock
Price per security
$1.3500
Deadline
Oversubscription
Accepted

Issuer

CIK
2051498
Entity
Corporation
Jurisdiction
DE
Address
1401 LAVACA STREET, #851
AUSTIN, TX 78701
Phone

Most recent fiscal year financials

Total assets
$682,327
Cash
Short-term debt
$38,756
Long-term debt
$1,050,000
Revenues
COGS
Taxes paid
Net income
$-406,429

View original on SEC EDGAR.